RGDO/Tobira—It’s intriguing that Dr. Fischer was CEO of OCRX (one of my SI charity picks) when OCRX in-licensed its ammonia scavenger, OCR-002.
Today’s PR on the reverse merger plays down Tobira’s HIV program. When you compare #msg-109912303 to the Mar 2014 PR you just posted, the difference is stark.
Market Data 
Markets 
AI
